Brevan Howard Capital Management’s Lifestance Health LFST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$521K Sell
48,685
-4,312
-8% -$33.3K ﹤0.01% 1429
2026
Q1
$338K Buy
52,997
+16,737
+46% +$116K ﹤0.01% 1546
2025
Q4
$255K Sell
36,260
-1,468
-4% -$8.86K ﹤0.01% 1453
2025
Q3
$208K Buy
37,728
+5,818
+18% +$28.5K ﹤0.01% 1734
2025
Q2
$165K Buy
+31,910
New +$191K ﹤0.01% 1744
2024
Q3
– Sell
-21,914
Closed -$108K – 1303
2024
Q2
$108K Buy
+21,914
New +$132K ﹤0.01% 964

Other funds holding LFST

Brevan Howard Capital Management's LFST Position: Q2 2026 in Review

Brevan Howard Capital Management reduced its Lifestance Health (LFST) stake by 8.1% in Q2 2026, selling an estimated $33.3K and leaving 48,685 shares worth $521K. The position accounts for ﹤0.01% of the portfolio, ranked #1429.

Brevan Howard Capital Management first reported a position in LFST in Q2 2024 and has held it in 6 quarters since. 288 funds tracked by Wall St. Rank hold LFST as of Q2 2026.

  • Brevan Howard Capital Management held 48,685 shares of Lifestance Health worth $521K as of Q2 2026.
  • Brevan Howard Capital Management sold 4,312 Lifestance Health shares in Q2 2026, an estimated $33.3K.
  • Lifestance Health made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #1429 holding.
  • Brevan Howard Capital Management first reported a position in Lifestance Health in Q2 2024 and has held it in 6 quarters since.
  • 288 funds tracked by Wall St. Rank held Lifestance Health as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.